Actively Recruiting
BOLSTER Program to Support Patients and Caregivers Facing Advanced Gynecologic and Gastrointestinal Cancers
Led by Dana-Farber Cancer Institute · Updated on 2026-06-18
600
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new program called Building Out Lifelines for Safety, Trust, Empowerment, and Renewal BOLSTER to support people with advanced gastrointestinal or gynecologic cancers who have complex care needs. This trial aims to improve quality of life, reduce symptoms and burden, and lower hospital care needs for patients and their family caregivers. The study is funded by the National Cancer Institute and involves about 300 patient-caregiver pairs. Participants are randomly assigned to one of two groups. One group receives usual care, including standard oncology visits and access to nurse and specialist appointments. The other group participates in the BOLSTER Program, which includes six telehealth sessions led by a nurse for patients and caregivers, two additional brief telehealth sessions for caregivers, and access to a website with personalized educational materials. All participants complete baseline visits and surveys at 6 and 12 weeks. Participation lasts about 12 weeks. During this time, participants complete questionnaires and telehealth visits. Researchers assess changes in quality of life, symptom management, healthcare use, anxiety, depression, and caregiver burden using various validated tools. Surveys at 6 and 12 weeks help measure these outcomes, and audio recordings of some sessions are collected. The study monitors both patients and their caregivers to evaluate the programs effects.
CONDITIONS
Brief Title
BOLSTER: Learning New Skills to Thrive
Research Team
A
Alexi Wright, MD, MPH
I
Irene Wang, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here